← FDA DRUG APPROVALS

FDA ANDA · ANDA202651

DILTIAZEM HYDROCHLORIDE

Sponsor: HIKMA FARMACEUTICA

APPLICATION
ANDA202651
TYPE
ANDA
ORIGINAL APPROVAL
2012-08-09
LATEST ACTION
2012-08-09
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription, Discontinued

Products

DILTIAZEM HYDROCHLORIDEPrescription
DILTIAZEM HYDROCHLORIDE 50MG/10ML · INJECTABLE · INJECTION
DILTIAZEM HYDROCHLORIDEPrescription
DILTIAZEM HYDROCHLORIDE 125MG/25ML · INJECTABLE · INJECTION
DILTIAZEM HYDROCHLORIDEDiscontinued
DILTIAZEM HYDROCHLORIDE 5MG/ML · INJECTABLE · INJECTION

Approval history

2012-08-09UNKNOWN · Original — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →